![Short term treatment with androgen blockage benefits prostate cancer patients.](/sites/default/files/assets/news/images/ln-prostate-cancer.jpg)
A study of over 800 prostate cancer patients showed that a short course of anti-androgen therapy was able to boost survival and reduce the spread of locally advanced cancer to distant locations in the body. The research showed that 6 months of therapy was sufficient whereas 3 months did not have the same results.